HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Benno Nuding Selected Research

Biomarkers (Surrogate Marker)

1/2020The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Benno Nuding Research Topics

Disease

8Breast Neoplasms (Breast Cancer)
10/2022 - 10/2017
3Neoplasms (Cancer)
11/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

3Hormones (Hormone)IBA
11/2020 - 01/2020
2ErbB Receptors (EGF Receptor)IBA
06/2020 - 01/2019
2AnthracyclinesIBA
01/2020 - 01/2019
2Docetaxel (Taxotere)FDA Link
01/2020 - 01/2019
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020 - 01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
11/2020
1ribociclibIBA
06/2020
1Letrozole (Femara)FDA LinkGeneric
06/2020
1Aromatase InhibitorsIBA
06/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1taxaneIBA
01/2020
1human ERBB2 proteinIBA
01/2020
1Epirubicin (Ellence)FDA LinkGeneric
01/2019

Therapy/Procedure

4Therapeutics
10/2022 - 10/2017
4Drug Therapy (Chemotherapy)
01/2020 - 10/2017